Nivedita Thakur
Neurology with Special Qualifications in Child Neurology · Houston, TXNPI 1013262286
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by UCB, Inc. at 28.9% of the total. 2025 is the largest year on record at $419, 5.3 times the $79 reported in 2019. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in TX, where the typical reported total is $920.
Across 33 payments — averaging $27.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$260
- Medtronic$120
- Biogen$105
- Jazz Pharmaceuticals Inc.$92
- Acadia Pharmaceuticals Inc$72
- Novartis$62
- plus $189 from 8 others
Across 88 payments — averaging $3559.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- PTC Therapeutics, Inc.$158K
- Teva Pharmaceuticals USA, Inc.$83K
- Travere Therapeutics, Inc.$73K
What the payments were for
- Food & beverage$900100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 7 | $260 |
| Medtronic | 2 | $120 |
| Biogen | 4 | $105 |
| Jazz Pharmaceuticals Inc. | 3 | $92 |
| Acadia Pharmaceuticals Inc | 3 | $72 |
| Novartis | 3 | $62 |
| Sunovion Pharmaceuticals Inc. | 2 | $34 |
| Pyros Pharmaceuticals, Inc. | 1 | $30 |
| Upsher-smith Laboratories LLC | 1 | $25 |
| Aucta Pharmaceuticals, Inc. | 3 | $24 |
| Greenwich Biosciences, Inc. | 1 | $24 |
| Aquestive Therapeutics, Inc. | 1 | $21 |
| Livanova USA, Inc. | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$900 in reported general payments places this provider in the 45th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Houston
- Huda ZoghbiHouston$5.5M
- Shade MoodyHouston$194K
- Mary Kay KoenigHouston$171K
- Gretchen von AllmenHouston$31K
- Victoria HardwickHouston$10K
- Joshua RotenbergHouston$9K
- Mered ParnesHouston$5K
- Sarah WilsonHouston$5K
- Roy EltermanDallas$5.9M
- Diana CastroDenton$343K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.